Telomir Pharmaceuticals, Inc. Common Stock (TELO)
NASDAQ·Healthcare·Biotechnology
$0.73
-6.72%
Mkt Cap $45.04M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+449.7%
Consensus $4.00 vs current $0.73